Franklin Street Advisors Inc G1 Therapeutics, Inc. Transaction History

Franklin Street Advisors Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$1.22 - $2.67 $59,780 - $130,830	49,000 Added 142.44%	83,400 $120,000
Q2 2023 Jul 13, 2023	BUY	$2.46 - $3.14 $3,050 - $3,893	1,240 Added 3.74%	34,400 $86,000
Q1 2023 Apr 12, 2023	BUY	$2.57 - $8.16 $25,700 - $81,600	10,000 Added 43.18%	33,160 $89,000
Q4 2021 Jan 26, 2022	BUY	$10.16 - $16.17 $21,945 - $34,927	2,160 Added 10.29%	23,160 $236,000
Q1 2021 May 04, 2021	BUY	$17.58 - $32.59 $369,179 - $684,390	21,000 New	21,000 $505,000
Q1 2020 Apr 16, 2020	SELL	$9.07 - $26.32 $72,560 - $210,560	-8,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$20.54 - $31.0 $164,320 - $248,000	8,000 New	8,000 $211,000
Q3 2019 Nov 14, 2019	SELL	$22.78 - $40.58 $182,240 - $324,640	-8,000 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$16.03 - $31.1 $128,240 - $248,800	8,000 New	8,000 $245,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Franklin Street Advisors Inc with notifications on news.